Literature DB >> 25724334

C-type lectin-like domain and fibronectin-like type II domain of phospholipase A(2) receptor 1 modulate binding and migratory responses to collagen.

Soichiro Takahashi1, Kazuhiro Watanabe1, Yosuke Watanabe1, Daisuke Fujioka1, Takamitsu Nakamura1, Kazuto Nakamura1, Jun-ei Obata1, Kiyotaka Kugiyama2.   

Abstract

Phospholipase A2 receptor 1 (PLA2R) mediates collagen-dependent migration. The mechanisms by which PLA2R interacts with collagen remain unclear. We produced HEK293 cells expressing full-length wild-type PLA2R or a truncated PLA2R that lacks fibronectin-like type II (FNII) domains or several regions of C-type lectin-like domain (CTLD). We show that the CTLD1-2 as well as the FNII domain of PLA2R are responsible for binding to collagen and for collagen-dependent migration. Thus, multiple regions and domains of the extracellular portion of PLA2R participate in the responses to collagen. These data suggest a potentially new mechanism for PLA2R-mediated biological response beyond that of a receptor for secretory PLA2.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Binding; Collagen; Fibronectin-like type II domain; Migration; Phospholipase A(2) receptor 1; Secretory phospholipase A(2)

Mesh:

Substances:

Year:  2015        PMID: 25724334     DOI: 10.1016/j.febslet.2015.02.016

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Interaction of reactive astrocytes with type I collagen induces astrocytic scar formation through the integrin-N-cadherin pathway after spinal cord injury.

Authors:  Masamitsu Hara; Kazu Kobayakawa; Yasuyuki Ohkawa; Hiromi Kumamaru; Kazuya Yokota; Takeyuki Saito; Ken Kijima; Shingo Yoshizaki; Katsumi Harimaya; Yasuharu Nakashima; Seiji Okada
Journal:  Nat Med       Date:  2017-06-19       Impact factor: 53.440

Review 2.  PLA2R and THSD7A: Disparate Paths to the Same Disease?

Authors:  Laurence H Beck
Journal:  J Am Soc Nephrol       Date:  2017-07-03       Impact factor: 10.121

Review 3.  The collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review).

Authors:  Maria C Melander; Henrik J Jürgensen; Daniel H Madsen; Lars H Engelholm; Niels Behrendt
Journal:  Int J Oncol       Date:  2015-08-12       Impact factor: 5.650

4.  Insights into Collagen Uptake by C-type Mannose Receptors from the Crystal Structure of Endo180 Domains 1-4.

Authors:  Patricia Paracuellos; David C Briggs; Federico Carafoli; Tan Lončar; Erhard Hohenester
Journal:  Structure       Date:  2015-10-15       Impact factor: 5.006

5.  Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo.

Authors:  Markus Friedemann; Brit Nacke; Albert Hagelgans; Carsten Jandeck; Nicole Bechmann; Martin Ullrich; Birgit Belter; Christin Neuber; Olga Sukocheva; Jens Pietzsch; Mario Menschikowski
Journal:  Oncotarget       Date:  2018-11-13

Review 6.  Perspectives in membranous nephropathy.

Authors:  Nicola M Tomas; Tobias B Huber; Elion Hoxha
Journal:  Cell Tissue Res       Date:  2021-04-06       Impact factor: 4.051

7.  Phospholipase A2 Receptor Gene Polymorphisms Alter its Functions and Present a Genetic Risk of an Increased Intima-Media Thickness of the Carotid Artery.

Authors:  Nguyen Van Si; Daisuke Fujioka; Kazuhiro Watanabe; Yosuke Watanabe; Kazunori Watanabe; Kazuto Nakamura; Kazuyuki Yamaguchi; Manabu Uematsu; Kiyotaka Kugiyama
Journal:  J Atheroscler Thromb       Date:  2016-03-29       Impact factor: 4.928

8.  PLA2R binds to the annexin A2-S100A10 complex in human podocytes.

Authors:  Maryline Fresquet; Thomas A Jowitt; Edward A McKenzie; Matthew D Ball; Michael J Randles; Rachel Lennon; Paul E Brenchley
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

9.  Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation.

Authors:  Maël Lateb; Hajar Ouahmi; Christine Payré; Vesna Brglez; Kevin Zorzi; Guillaume Dolla; Mohamad Zaidan; Sonia Boyer-Suavet; Bertrand Knebelmann; Thomas Crépin; Cécile Courivaud; Noémie Jourde-Chiche; Vincent Esnault; Gérard Lambeau; Barbara Seitz-Polski
Journal:  J Immunol Res       Date:  2019-12-30       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.